Plastic Surgery Doctors in Montclair, NJ Accepting Medicare

6 Plastic Surgery doctors found. Showing 1 - 6

Dr. Andrea Cacciarelli, Plastic Surgery Medicare: May Accept Medicare Assignments Practice Location: 29 Park St, Montclair, NJ 07042 Phone: 973-364-0135

Dr. Sheila Ann Bond, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 39 S Fullerton Ave, 3rd Flr., Montclair, NJ 07042 Phone: 973-509-0007    Fax: 973-509-0733

Dr. Allen D Rosen, M.D. Plastic Surgery Medicare: May Accept Medicare Assignments Practice Location: 37 N Fullerton Ave, The Plastic Surgery Group, Montclair, NJ 07042 Phone: 973-233-1933    Fax: 973-233-1934

Dr. Valerie J Ablaza, MD Plastic Surgery Medicare: May Accept Medicare Assignments Practice Location: 37 N Fullerton Ave, The Plastic Surgery Group, Montclair, NJ 07042 Phone: 973-233-1933    Fax: 973-233-1934

Dr. Vincent C. Giampapa, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 89 Valley Rd, Montclair, NJ 07042 Phone: 973-746-3535

Dr. Charbel T Chalfoun, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 37 North Fullerton Ave, Montclair, NJ 07042 Phone: 973-233-1933    Fax: 973-233-1934

News Archive

AMAG fourth quarter total revenues increase to $17.2 million

AMAG Pharmaceuticals, Inc. a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia, today reported unaudited consolidated financial results for the fourth quarter and year ended December 31, 2010.

Stem cell therapy can reduce lung inflammation in mouse model of COPD and cystic fibrosis

A new study has found that stem cell therapy can reduce lung inflammation in an animal model of chronic obstructive pulmonary disease (COPD) and cystic fibrosis. Although, still at a pre-clinical stage, these findings have important potential implications for the future treatment of patients.

Mylan receives shareholders' approval for proposed Perrigo acquisition

Mylan N.V. today announced that its shareholders have approved Mylan's proposed acquisition of Perrigo Company plc and the related issuance of Mylan ordinary shares to Perrigo's shareholders at an extraordinary general meeting of shareholders held today.

TherapeuticsMD announces FDA approval of BIJUVA capsules to manage vasomotor symptoms of menopause

TherapeuticsMD, Inc., an innovative women's healthcare company, today announced that the United States Food and Drug Administration has approved BIJUVA (estradiol and progesterone) capsules, 1 mg/100 mg, the first and only FDA-approved bio-identical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate to severe vasomotor symptoms (commonly known as hot flashes or flushes) due to menopause in women with a uterus.

Read more Medical News

› Verified 2 days ago